RHBDF1 deficiency suppresses melanoma glycolysis and enhances efficacy of immunotherapy by facilitating glucose-6-phosphate isomerase degradation via TRIM32
Article in Pharmacological Research (November 2023)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Pharmacological Research (November 2023)
Article in FEBS Open Bio (April 2023)
Article in Biotechnology and Genetic Engineering Reviews (March 2023)